文献速递角膜与眼表疾病

不同LT-α表达水平的干眼症患者泪液蛋白标志物评估

Evaluation of Tear Protein Markers in Dry Eye Disease with Different Lymphotoxin-Alpha Expression Levels.
PubMed 文献 · Am J Ophthalmol · 2020-03-21

该前瞻性横断面研究比较了正常人与高、低淋巴毒素-α(LT-α)水平干眼症患者的泪液蛋白标志物。结果显示高LT-α干眼症组多种炎症因子水平显著升高,且泪液IL-1Ra与颞侧结膜充血指数正相关、与Schirmer I试验负相关,提示其或可替代Schirmer I试验。

要点

  • 高LT-α干眼症组泪液TNF-α、IL-10、IL-1β、IL-1Ra、IL-17A和IL-12/23 p40水平显著高于低LT-α组。
  • 泪液IL-1Ra在干眼症患者中升高,与颞侧结膜充血指数正相关、与Schirmer I试验负相关。
  • 高LT-α干眼症可能具有不同的发病机制。

核心结论

  • 泪液IL-1Ra水平可能是替代Schirmer I试验的潜在生物标志物。
  • 高LT-α干眼症患者多种泪液蛋白标志物水平升高,提示其发病机制可能不同。

研究设计与样本

  • 前瞻性横断面研究,纳入高LT-α干眼症组(右眼33眼、左眼21眼)、低LT-α干眼症组(右眼27眼、左眼39眼)和对照组(各20眼)。
  • 以泪液LT-α≤700 pg/mL为低值组、>700 pg/mL为高值组,用微球免疫分析法检测12种蛋白标志物并评估眼表参数。

主要发现

  • 双眼高LT-α干眼症组TNF-α、IL-10、IL-1β、IL-1Ra、IL-17A和IL-12/23 p40水平显著高于低LT-α组(P < .01)。
  • 高LT-α干眼症组中,SPEED与IL-10(R = 0.43, P = .013)、IL-1β(R = 0.48, P = .005)、IL-12/23 p40(R = 0.50, P = .003)相关,IL-12/23 p40与OSDI相关(R = 0.35, P = .049),EGF与角膜荧光素染色评分相关(R = -0.36, P = .038)。
  • 低LT-α干眼症组中,SPEED与IL-10(R = -0.39, P = .046)、TNF-α(R = -0.39, P = .047)、IL-17A(R = -0.48, P = .013)相关,OSDI与TNF-α(R = -0.47, P = .017)、IL-17A(R = -0.46, P = .018)相关,IL-6与泪膜破裂时间相关(R = -0.40, P = .044)。
  • 干眼症患者泪液IL-1Ra水平显著升高,与颞侧结膜充血指数正相关、与Schirmer I试验负相关(P < .05)。

临床怎么用

  • 可通过检测泪液LT-α水平对干眼症患者进行亚型分类,高LT-α患者可能需针对不同炎症通路的治疗。
  • 泪液IL-1Ra水平有潜力作为替代Schirmer I试验的客观指标,用于评估干眼症严重程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare tear protein markers between normal subjects and patients with dry eye (DE) and high and low lymphotoxin-alpha (LT-α) levels. DESIGN: Prospective cross-sectional study. METHODS: Patients with DE were divided into low (≤700 pg/mL) and high (>700 pg/mL) LT-α groups. Twelve protein markers were measured by microsphere-based immunoassay and ocular surface parameters were determined in right eyes (33 high LT-α DE, 27 low LT-α DE, and 20 control eyes) and left eyes (21 high LT-α DE, 39 low LT-α DE, and 20 control eyes). RESULTS: In both eyes, tumor necrosis factor-α (TNF-α), interleukin (IL)-10, IL-1β, IL-1 receptor antagonist (IL-1Ra), IL-17A, and IL-12/23 p40 levels in high LT-α DE were significantly higher (P < .01) than in low LT-α DE. Significant correlations identified in high LT-α DE were: Standard Patient Evaluation Eye Dryness with IL-10 (R = 0.43, P = .013), IL-1β (R = 0.48, P = .005), and IL-12/23 p40 (R = 0.50, P = .003), IL-12/23 p40 with ocular surface disease index (R = 0.35, P = .049), and epidermal growth factor with corneal fluorescein staining score (R = -0.36, P = .038). Significant correlations in low LT-α DE were: Standard Patient Evaluation Eye Dryness with IL-10 (R = -0.39, P = .046), TNF-α (R = -0.39, P = .047), and IL-17A (R = -0.48, P = .013), ocular surface disease index with TNF-α (R = -0.47, P = .017) and IL-17A (R = -0.46, P = .018), and IL-6 with tear breakup time (R = -0.40, P = .044). Lastly, IL-1Ra levels significantly increased in DE patients, positively correlated with temporal conjunctival hyperemia index, and negatively correlated with Schirmer I test (P < .05). CONCLUSIONS: Our study identified tear IL-1Ra level as a potential biomarker to replace the Schirmer I test. Multiple tear protein marker levels increased in high LT-α DE, indicating that high LT-α DE might have a different pathogenesis.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Chen H, Chen H, Liang L, et al. Evaluation of Tear Protein Markers in Dry Eye Disease with Different Lymphotoxin-Alpha Expression Levels. Am J Ophthalmol. 2020. PMID: 32209340. doi:10.1016/j.ajo.2020.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。